Please use this identifier to cite or link to this item:
http://hdl.handle.net/10668/17844
Title: | Case Report: Successful Response to Intravenous Immunoglobulin and Steroid Pulses in a Renal Transplant Recipient With Severe Covid-19 Disease and Associated Acute Allograft Failure. |
Authors: | Rosa-Guerrero, Pedro Trujillo-Aguilera, Antonio Molina, Juan Navas, Ana López-Martín, Cristina Jurado, Aurora Rodríguez-Benot, Alberto Torres-De-Rueda, Álvaro |
Keywords: | Covid-19;SARS-CoV-2;case report;cytokine storm;intravenous immunoglobulin;kidney transplantation;steroids |
metadata.dc.subject.mesh: | Acute Disease Anti-Inflammatory Agents COVID-19 Disease Progression Graft Rejection Humans Immunoglobulins, Intravenous Immunosuppressive Agents Kidney Failure, Chronic Kidney Transplantation Male Middle Aged Renal Dialysis Respiration, Artificial SARS-CoV-2 Steroids Transplant Recipients Transplantation, Homologous COVID-19 Drug Treatment |
Issue Date: | 11-May-2021 |
Abstract: | The impact of Covid-19 pneumonia caused by SARS-CoV-2 on transplanted populations under chronic immunosuppression seems to be greater than in normal population. Clinical management of the disease, particularly in those patients worsening after a cytokine storm, with or without allograft impairment and using available therapeutic approaches in the absence of specific drugs to fight against the virus, involves a major challenge for physicians. We herein provide evidence of the usefulness of high-dose intravenous immunoglobulin (IVIG) combined with steroid pulses to successfully treat a case of Covid-19 pneumonia in a single-kidney transplanted patient with mechanical ventilation and hemodialysis requirements in the setting of a cytokine storm. A rapid decrease in the serum level of inflammatory cytokines, particularly IL-6, IL-8, TNF-α, MCP-1 and IL-10, as well as of acute-phase reactants such as ferritin, D-dimer and C-reactive protein was observed after the IVIG infusion and methylprednisolone bolus administration with a parallel clinical improvement and progressive allograft function recovery, allowing the patient's final discharge 40 days after the treatment onset. The immunomodulatory effect of IVIG together with the anti-inflammatory and immunosuppressive potential of steroids could be an alternative strategy to treat severe cases of Covid-19 pneumonia associated with an uncontrolled inflammatory response in transplanted populations. |
URI: | http://hdl.handle.net/10668/17844 |
metadata.dc.identifier.doi: | 10.3389/fimmu.2021.671013 |
Appears in Collections: | Producción 2020 |
Files in This Item:
File | Size | Format | |
---|---|---|---|
PMC8148337.pdf | 844,13 kB | Adobe PDF | View/Open |
This item is protected by original copyright |
This item is licensed under a Creative Commons License